CYP3A4 and hydrops fetalis: Moreover, both verapamil and diltiazem can significantly interact with beta‐blockers and CYP3A4 substrates, heightening the risk of bradycardia, atrioventricular block, and worsening HF—especially when administered intravenously, at high doses, or in the presence of conduction abnormalities.50